Sandbox:Maria: Difference between revisions
Jump to navigation
Jump to search
Sara Mohsin (talk | contribs) No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
== Hepatitis B == | |||
=== Epidemiology === | |||
=== Fisiopathology === | |||
=== Clinical features === | |||
=== Management === | |||
{| | {| | ||
|+'''Classification of Waldenstrom macroglobulinemia (WM) and Related Disorders''' | |+'''Classification of Waldenstrom macroglobulinemia (WM) and Related Disorders''' | ||
| Line 33: | Line 40: | ||
| style="background:#F5F5F5;" align="center" + | - | | style="background:#F5F5F5;" align="center" + | - | ||
|} | |} | ||
Revision as of 16:06, 30 September 2020
Hepatitis B
Epidemiology
Fisiopathology
Clinical features
Management
| Criteria | Symptomatic WM | Asymptomatic WM | IgM-Related Disorders | MGUS |
|---|---|---|---|---|
| IgM monoclonal protein | + | + | + | + |
| Bone marrow infiltration | + | + | - | - |
| Symptoms attributable to IgM | + | - | + | - |
| Symptoms attributable to tumor infiltration | + | - | - | - |
References
- ↑ Kiran U, Aggarwal S, Choudhary A, Uma B, Kapoor PM (2017). "The blalock and taussig shunt revisited". Ann Card Anaesth. 20 (3): 323–330. doi:10.4103/aca.ACA_80_17. PMC 5535574. PMID 28701598.